Literature DB >> 19855066

Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury.

William H Barry1, Xiu Q Zhang, Michael E Halkos, Jakob Vinten-Johansen, Noriko Saegusa, Kenneth W Spitzer, Nobuhiro Matsuoka, Michael Sheets, Narayanam V Rao, Thomas P Kennedy.   

Abstract

Heparin desulfated at the 2-O and 3-O positions (ODSH) decreases canine myocardial reperfusion injury. We hypothesized that this occurs from effects on ion channels rather than solely from anti-inflammatory activities, as previously proposed. We studied closed-chest pigs with balloon left anterior descending coronary artery occlusion (75-min) and reperfusion (3-h). ODSH effects on [Na(+)](i) (Na Green) and [Ca(2+)](i) (Fluo-3) were measured by flow cytometry in rabbit ventricular myocytes after 45-min of simulated ischemia [metabolic inhibition with 2 mM cyanide, 0 glucose, 37 degrees C, pacing at 0.5 Hz; i.e., pacing-metabolic inhibition (PMI)]. Na(+)/Ca(2+) exchange (NCX) activity and Na(+) channel function were assessed by voltage clamping. ODSH (15 mg/kg) 5 min before reperfusion significantly decreased myocardial necrosis, but neutrophil influx into reperfused myocardium was not consistently reduced. ODSH (100 microg/ml) reduced [Na(+)](i) and [Ca(2+)](i) during PMI. The NCX inhibitor KB-R7943 (10 microM) or the late Na(+) current (I(Na-L)) inhibitor ranolazine (10 microM) reduced [Ca(2+)](i) during PMI and prevented effects of ODSH on Ca(2+) loading. ODSH also reduced the increase in Na(+) loading in paced myocytes caused by 10 nM sea anemone toxin II, a selective activator of I(Na-L). ODSH directly stimulated NCX and reduced I(Na-L). These results suggest that in the intact heart ODSH reduces Na(+) influx during early reperfusion, when I(Na-L) is activated by a burst of reactive oxygen production. This reduces Na(+) overload and thus Ca(2+) influx via NCX. Stimulation of Ca(2+) extrusion via NCX later after reperfusion may also reduce myocyte Ca(2+) loading and decrease infarct size.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855066      PMCID: PMC2806141          DOI: 10.1152/ajpheart.00316.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  48 in total

1.  Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death.

Authors:  Javier Inserte; David Garcia-Dorado; Marisol Ruiz-Meana; Ferran Padilla; José A Barrabés; Pilar Pina; Luis Agulló; Hans Michael Piper; Jordi Soler-Soler
Journal:  Cardiovasc Res       Date:  2002-09       Impact factor: 10.787

2.  Activation of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit ventricular myocytes during metabolic inhibition.

Authors:  F Li; K Sugishita; Z Su; I Ueda; W H Barry
Journal:  J Mol Cell Cardiol       Date:  2001-12       Impact factor: 5.000

3.  Phenylarsine oxide induces mitochondrial permeability transition, hypercontracture, and cardiac cell death.

Authors:  P Korge; J I Goldhaber; J N Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

4.  Heparin and heparan sulfate disaccharides bind to the exchanger inhibitor peptide region of Na+/Ca2+ exchanger and reduce the cytosolic calcium of smooth muscle cell lines. Requirement of C4-C5 unsaturation and 1--> 4 glycosidic linkage for activity.

Authors:  Samuel K Shinjo; Ivarne L S Tersariol; Vitor Oliveira; Clóvis R Nakaie; Maria E M Oshiro; Alice T Ferreira; Isabel A Santos; Carl P Dietrich; Helena B Nader
Journal:  J Biol Chem       Date:  2002-10-08       Impact factor: 5.157

5.  Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.

Authors:  V H Thourani; S S Brar; T P Kennedy; L R Thornton; J A Watts; R S Ronson; Z Q Zhao; A L Sturrock; J R Hoidal; J Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

6.  Stoichiometry of Na+-Ca2+ exchange is 3:1 in guinea-pig ventricular myocytes.

Authors:  Masamitsu Hinata; Hisao Yamamura; Libing Li; Yasuhide Watanabe; Tomokazu Watano; Yuji Imaizumi; Junko Kimura
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

Review 7.  Role of the mitochondrial permeability transition in myocardial disease.

Authors:  James N Weiss; Paavo Korge; Henry M Honda; Peipei Ping
Journal:  Circ Res       Date:  2003-08-22       Impact factor: 17.367

8.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

9.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Comparison of sarcoplasmic reticulum Ca2+-ATPase function in human, dog, rabbit, and mouse ventricular myocytes.

Authors:  Zhi Su; Fenghua Li; Kenneth W Spitzer; Atsushi Yao; Michael Ritter; William H Barry
Journal:  J Mol Cell Cardiol       Date:  2003-07       Impact factor: 5.000

View more
  9 in total

Review 1.  Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.

Authors:  Anke C Fender; Reza Wakili; Dobromir Dobrev
Journal:  Pharmacol Res       Date:  2019-05-02       Impact factor: 7.658

2.  Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling.

Authors:  Xiu Q Zhang; Ruhang Tang; Ling Li; Amanda Szucsik; Hadi Javan; Noriko Saegusa; Ken W Spitzer; Craig H Selzman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

3.  Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes.

Authors:  Chunping Qian; Jihua Ma; Peihua Zhang; Antao Luo; Chao Wang; Zhiqiang Ren; Linghao Kong; Shuo Zhang; Xiaojing Wang; Ying Wu
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

4.  The Driving Force of the Na/Ca-Exchanger during Metabolic Inhibition.

Authors:  Antonius Baartscheer; Cees A Schumacher; Ruben Coronel; Jan W T Fiolet
Journal:  Front Physiol       Date:  2011-03-11       Impact factor: 4.566

5.  The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injury.

Authors:  Massimo Collino; Collino Massimo; Alessandro Pini; Pini Alessandro; Rosanna Mastroianni; Mastroianni Rosanna; Elisa Benetti; Benetti Elisa; Cecilia Lanzi; Lanzi Cecilia; Daniele Bani; Bani Daniele; Chini Jacopo; Marco Manoni; Manoni Marco; Roberto Fantozzi; Fantozzi Roberto; Emanuela Masini; Masini Emanuela
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

Review 6.  Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.

Authors:  Afonso Caricati-Neto; Paolo Ruggero Errante; Francisco Sandro Menezes-Rodrigues
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

Review 7.  The Na+/Ca²+ exchanger in cardiac ischemia/reperfusion injury.

Authors:  Sai Chen; Shuzhuang Li
Journal:  Med Sci Monit       Date:  2012-11

8.  Early low-anticoagulant desulfated heparin after traumatic brain injury: Reduced brain edema and leukocyte mobilization is associated with improved watermaze learning ability weeks after injury.

Authors:  Katsuhiro Nagata; Yujin Suto; John Cognetti; Kevin D Browne; Kenichiro Kumasaka; Victoria E Johnson; Lewis Kaplan; Joshua Marks; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2018-05       Impact factor: 3.697

9.  Heparin Oligosaccharides Have Antiarrhythmic Effect by Accelerating the Sodium-Calcium Exchanger.

Authors:  Carlos M G de Godoy; Ênio R Vasques; Afonso Caricati-Neto; José G P Tavares; Beatriz J Alves; Juliana Duarte; Regiane Miranda-Ferreira; Marcelo A Lima; Helena B Nader; Ivarne L Dos Santos Tersariol
Journal:  Front Cardiovasc Med       Date:  2018-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.